Literature DB >> 34979437

Sleep and anxiety: From mechanisms to interventions.

Sarah L Chellappa1, Daniel Aeschbach2.   

Abstract

Anxiety is the most common mental health problem worldwide. Epidemiological studies show that sleep disturbances, particularly insomnia, affect ∼50% of individuals with anxiety, and that insufficient sleep can instigate or further exacerbate it. This review outlines brain mechanisms underlying sleep and anxiety, by addressing recent human functional/structural imaging studies on brain networks underlying the anxiogenic impact of sleep loss, and the beneficial effect of sleep on these brain networks. We discuss recent developments from human molecular imaging studies that highlight the role of specific brain neurotransmitter mechanisms, such as the adenosinergic receptor system, on anxiety, arousal, and sleep. This review further discusses frontline sleep interventions aimed at enhancing sleep in individuals experiencing anxiety, such as nonbenzodiazepines/antidepressants, lifestyle and sleep interventions and cognitive behavioral therapy for insomnia. Notwithstanding therapeutic success, up to ∼30% of individuals with anxiety can be nonresponsive to frontline treatments. Thus, we address novel non-invasive brain stimulation techniques that can enhance electroencephalographic slow waves, and might help alleviate sleep and anxiety symptoms. Collectively, these findings contribute to an emerging biological framework that elucidates the interrelationship between sleep and anxiety, and highlight the prospect of slow wave sleep as a potential therapeutic target for reducing anxiety.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adenosine; Anxiety; Functional magnetic resonance imaging; Molecular brain imaging; Sleep; Sleep interventions; Sleep loss

Mesh:

Year:  2021        PMID: 34979437     DOI: 10.1016/j.smrv.2021.101583

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  6 in total

1.  Novel Macrocyclic Urea Orexin Receptor Agonists for Treating Sleep Disorders.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2022-06-21       Impact factor: 4.632

2.  Novel 3-Aminopyrrolidine and Piperidine Macrocyclic Orexin Receptor Agonists for Treating Sleep Disorders.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2022-08-12       Impact factor: 4.632

3.  Distinct functional brain abnormalities in insomnia disorder and obstructive sleep apnea.

Authors:  Weiwei Duan; Xia Liu; Liangliang Ping; Shushu Jin; Hao Yu; Man Dong; Fangfang Xu; Na Li; Ying Li; Yinghong Xu; Zhe Ji; Yuqi Cheng; Xiufeng Xu; Cong Zhou
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-09-12       Impact factor: 5.760

Review 4.  Adenosine, caffeine, and sleep-wake regulation: state of the science and perspectives.

Authors:  Carolin Franziska Reichert; Tom Deboer; Hans-Peter Landolt
Journal:  J Sleep Res       Date:  2022-05-16       Impact factor: 5.296

5.  Morning blue light treatment improves sleep complaints, symptom severity, and retention of fear extinction memory in post-traumatic stress disorder.

Authors:  John R Vanuk; Edward F Pace-Schott; Ayla Bullock; Simon Esbit; Natalie S Dailey; William D S Killgore
Journal:  Front Behav Neurosci       Date:  2022-09-12       Impact factor: 3.617

6.  Circadian and Sleep Modulation of Dreaming in Women with Major Depression.

Authors:  Angelina Birchler-Pedross; Sylvia Frey; Christian Cajochen; Sarah L Chellappa
Journal:  Clocks Sleep       Date:  2022-02-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.